NV.gov
All DPBH Technical Bulletins
General topics
- Noro Rota Submission to NSPHL Technical Bulletin July 2026
- Bicillin Continued Shortage Technical Bulletin June 2026
- Health Considerations and Mass Gatherings Technical Bulletin May 2026
- Measles March 2026 Technical Bulletin
- ACIP BOH Technical Bulletin March 2026
- RSV Extension Technical Bulletin March 2026
- Respiratory Season December 2025 DPBH Technical Bulletin
- Pertussis in Nevada – Recommendations for Health Care Providers .pdf
- Measles in the United States, Recommendations for Health Care Providers
- Nevada State Public Health Laboratory Guidance for Tuberculosis and Bacillus Testing
- Accelerated Testing and Surveillance for Avian Influenza A (H5N1) Human Cases
- Blood Lead Level Testing in Nevada, Reporting Requirements
- IV Fluid Supply Following Closure of Manufacturing Facility in North Carolina
- Blood Lead Level Testing in Nevada, Reporting Requirements
- BICILLIN® L-A shortage and Syphilis treatment – Current situation
- CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024
- Tuberculosis Drug Susceptibility Testing for Pyrazinamide Suspended by Nevada State Public Health Laboratory as of July 29, 2024
- Summer Surveillance for Avian Influenza A (H5N1) Human Cases
- Meningococcal Disease Associated with Travel to Saudi Arabia, Recommendations for Health Care Providers
- Invasive Body Decoration, Serums for Healing
- Increased Incidence of Measles in United States, Recommendations for Health Care Providers
- Latent Tuberculosis Infection Reporting Requirements and Updates to Nevada Administrative Code Chapter 441A
- Syphilis in Nevada and Updates to Nevada Administrative Code 441A
- Establishment of Central Nevada Health District and Communicable Disease Reporting
- Electronic Reporting and Medical Facility Record Reporting
- CDC Updated Respiratory Virus Guidance (including COVID-19)
- Laboratory Reporting Negative HIV and Hep C Tests
- Reporting Breast Density Information to Patients
- Updates to NAC 441A, Regarding Reportable Communicable Diseases in Nevada
- CDC Provides New Laboratory Recommendations for Syphilis Testing
- Candida auris regulation changes
- Concerning Tuberculosis Trends and Guidance to Identify and Eliminate Tuberculosis
- Centers for Disease Control Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children
- National Shortage of Erythromycin 0.5% Ophthalmic Ointment
- FDA Approves Use of RSV Immunization for Pregnant Individuals to Protect Infants
- Hantavirus in Nevada
- Updated Operational Guidance for Implementation of CDC’s Hepatitis C Infection Testing Recommendations
- FDA Approves Use of Respiratory Syncytial Virus (RSV) Immunization for Infants and Children
- Use Limitations for Portable and Mobile X-ray Machines
- FDA Approves Use of Respiratory Syncytial Virus Vaccines (RSV) for Adults 60 and Older
- New Infectious Disease Inter-Facility Transfer Form, Candida auris Case Report Form, and Educational Tool for Candida auris
- Residential Facilities for Groups and Utilizing a Syringe to Measure the Dose of Oral Medications
- Bicillin® L-A Shortage and Syphilis Treatment
- Marburg Virus Disease Outbreaks in Equatorial Guinea and Tanzania
- Tuberculosis GeneXpert MTB/Rif® Assay Detection of Rifampin Resistance: Immediate Specimen Submission to the Nevada State Public Health Laboratory
- RSV, Influenza and COVID-19
- Respiratory Syncytial Virus (RSV) Update
- Proper Disposal of Medical Radioactive Waste
- Patient Denial of Rights Reporting Requirements to the Commission on Behavioral Health
- Rising Rates of Congenital Syphilis in Nevada and Updated Syphilis Screening Requirements for Pregnant Women
- Extension of the Influenza Surveillance Season
- Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Origin
- Tuberculosis Rapid Detection DNA Tests, NAATs and PCRs
- Candida auris
- BioPlex 2200 Syphilis Total & RPR Test Kit Recall
- Updated March 1, 2022 - FDA Recall on Powdered Infant Formula and Multistate Investigation of Cronobacter sakazakii Infections Associated with Powdered Infant Formula
- New Vaccination Requirement for Nevada Public, Private, and Charter Schools
- Requirements for HIV and STD Testing
- Sexually Transmitted Infections Treatment Guidelines, 2021
- CDC Recommendations for Hepatitis C Screening Among Adults
- New Immunization Exemption Requirement for Nevada Universities
- New Vaccination Requirement and Immunization Exemption Requirement for Nevada Public, Private Schools, and Charter Schools
- New Immunization Exemption Requirement for Nevada Child Care Facilities and Accommodation Facilities
- PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis) for HIV Prevention and Care
- Expedited Partner Therapy
- Human Trafficking Training
- Ebola Virus Disease
- Dietitian Ordering of Diets, Hospital Granting Clinical Privileges to Licensed Dietitians & Requirements for a Medical Facility to Take Necessary Actions to Ensure Special Diets Comply with Prescribing Provider’s Order or Prescription
- Radiation Control Programs-Technical Bulletins
COVID-19
Current and previous technical bulletins about COVID-19 can be found on the web page linked here.
Mpox
- CDC Health Alert Network Health Update: Potential Risk for New Mpox Cases
- Monkeypox Virus Guidance: Infection Control and Prevention in Health Care Settings
- Monkeypox Virus Guidance for Health Care Providers – Clinical Considerations for Treatment, Pain Management and Severe Manifestations of Monkeypox among Immunocompromised Persons
- Monkeypox Virus Guidance: Infection Control and Prevention for Patients in a Home Setting
- JYNNEOS Vaccine Authorized by the FDA for Emergency Use Authorization
- Monkeypox: Mandatory Reporting of Extraordinary Occurrence of Illness
- Monkeypox Virus Vaccine Guidance and Recommendations
- Monkeypox Virus Guidance for Health Care Providers – Clinical Recognition, Testing and Reporting
- Monkeypox Virus Guidance for Health Care Providers – Tecovirimat Treatment
- Updated Case-finding Guidance: Monkeypox Outbreak- United States, 2022
- CDC and Health Partners Responding to Monkeypox Case in the U.S.
- Immunization Program-Technical Bulletins